Author/Authors :
REZVAN, H Iranian Blood Transfusion Organisation , MOTALLEBI, Z Iranian Blood Transfusion Organisation , JALILI, M.A Iranian Blood Transfusion Organisation , MOUSAVI HOSSEINI, K Iranian Blood Transfusion Organisation , POURFATH ELAH, A.A Iranian Blood Transfusion Organisation
Abstract :
Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed.
